Literature DB >> 12913183

Nondopaminergic symptomatic therapies for Parkinson's disease: turn on or turn off?

Andrew Feigin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12913183     DOI： 10.1212/wnl.61.3.286

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Adenosine and its receptors as therapeutic targets: An overview.

Authors:  Sakshi Sachdeva; Monika Gupta
Journal:  Saudi Pharm J       Date:  2012-06-23       Impact factor: 4.330

Review 2.  Treatment of Parkinson's disease : what's on the horizon?

Authors:  Stacy S Wu; Steven J Frucht
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Adenosine A2A Receptor Gene Knockout Prevents l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia by Downregulation of Striatal GAD67 in 6-OHDA-Lesioned Parkinson's Mice.

Authors:  Su-Bing Yin; Xiao-Guang Zhang; Shuang Chen; Wen-Ting Yang; Xia-Wei Zheng; Guo-Qing Zheng
Journal:  Front Neurol       Date:  2017-03-21       Impact factor: 4.003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.